Sonora Investment Management, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Sonora Investment Management, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2021$6,905,000
+1.4%
6,730,000
+5.7%
0.54%
-3.7%
Q4 2020$6,807,000
+1.7%
6,370,000
-0.2%
0.56%
-8.9%
Q3 2020$6,691,000
-17.3%
6,385,000
-3.3%
0.62%
-25.1%
Q2 2020$8,086,000
+15.9%
6,605,000
-1.9%
0.83%
+0.1%
Q1 2020$6,977,000
-29.6%
6,730,000
-28.4%
0.83%
-11.7%
Q4 2019$9,915,000
+5.1%
9,405,000
-1.2%
0.94%
-4.7%
Q3 2019$9,430,000
+2.0%
9,520,000
+6.7%
0.98%
-4.8%
Q2 2019$9,242,000
+3.4%
8,925,000
+2.1%
1.03%
-5.6%
Q1 2019$8,935,000
+23.2%
8,745,000
+19.8%
1.09%
+4.0%
Q4 2018$7,250,000
-7.0%
7,300,000
-1.2%
1.05%
-2.3%
Q3 2018$7,792,000
+3.0%
7,390,000
-0.9%
1.08%
-7.7%
Q2 2018$7,568,000
-99.9%
7,455,000
+5.0%
1.17%
+9.8%
Q1 2018$6,681,214,000
+20.1%
7,100,000
+27.4%
1.06%
+18.8%
Q4 2017$5,562,541,000
+10.6%
5,575,000
+12.6%
0.90%
+2.5%
Q3 2017$5,029,596,0004,950,0000.87%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,138,000$29,510,0003.72%
PFM Health Sciences, LP 45,910,000$46,002,0001.72%
Cheyne Capital Management (UK) LLP 2,320,000$2,330,0001.47%
ADVENT CAPITAL MANAGEMENT /DE/ 41,077,000$41,277,0000.66%
SSI INVESTMENT MANAGEMENT LLC 9,071,000$9,068,0000.50%
PALISADE CAPITAL MANAGEMENT, LP 14,548,000$14,612,0000.34%
RWC Asset Management LLP 7,500,000$7,552,0000.21%
KBC Group NV 400,000$40,316,0000.15%
PROSPECTOR PARTNERS LLC 1,000,000$1,000,0000.12%
MACKAY SHIELDS LLC 11,822,000$11,816,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders